These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34263565)

  • 21. The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective.
    Lee ST; Emmett LM; Pattison DA; Hofman MS; Bailey DL; Latter MJ; Francis RJ; Scott AM
    J Nucl Med; 2022 Jun; 63(6):819-822. PubMed ID: 35393349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emulsion Technology in Nuclear Medicine: Targeted Radionuclide Therapies, Radiosensitizers, and Imaging Agents.
    Winuprasith T; Koirala P; McClements DJ; Khomein P
    Int J Nanomedicine; 2023; 18():4449-4470. PubMed ID: 37555189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economics of New Molecular Targeted Personalized Radiopharmaceuticals.
    Cutler CS
    Semin Nucl Med; 2019 Sep; 49(5):450-457. PubMed ID: 31470937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SNMMI Leadership Update: An Exciting Time for Nuclear Medicine and Molecular Imaging.
    Schwarz SW
    J Nucl Med; 2017 Jun; 58(6):19N. PubMed ID: 28572297
    [No Abstract]   [Full Text] [Related]  

  • 25. Nuclear imaging in cancer theranostics.
    Del Vecchio S; Zannetti A; Fonti R; Pace L; Salvatore M
    Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):152-63. PubMed ID: 17420716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Global Trends Survey for Targeted Radionuclide Therapy].
    Hanaoka K; Maeda T; Miyaji N; Sakaguchi K; Yoneyama H; Ogawa M; Tsushima H
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2018 Dec; 74(12):1443-1448. PubMed ID: 30568095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear medicine theranostics comes of age.
    Herrmann K; Kraus BJ; Hadaschik B; Kunikowska J; van Poppel H; N'Dow J; Sartor O; Oyen WJG
    Lancet Oncol; 2021 Nov; 22(11):1497-1498. PubMed ID: 34735807
    [No Abstract]   [Full Text] [Related]  

  • 28. Radiopharmaceutical enhancement by drug delivery systems: A review.
    Kleynhans J; Grobler AF; Ebenhan T; Sathekge MM; Zeevaart JR
    J Control Release; 2018 Oct; 287():177-193. PubMed ID: 30086338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current applications and perspectives of diagnostic nuclear medicine in oncology. Task Group of Oncology.
    Bombardieri E; Carrio I; Gonzalez P; Serafini A; Turner JH; Virgolini I; Maffioli L
    Int J Oncol; 1999 May; 14(5):877-90. PubMed ID: 10200337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Present and future of target therapies and theranostics: refining traditions and exploring new frontiers-highlights from annals of Nuclear Medicine 2021.
    Pini C; Gelardi F; Sollini M
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3613-3621. PubMed ID: 35870007
    [No Abstract]   [Full Text] [Related]  

  • 31. Potential Significant Changes in Nuclear Regulatory Commission Policies Regarding Training and Experience Requirements for the Use of Radiopharmaceuticals.
    Wallner PE; Lieto RP; Dillehay GL; Ghesani MV; Rosenthal SA; Rosenzweig KE; Steinberg ML; Yoo DC; Small W
    J Am Coll Radiol; 2021 Feb; 18(2):312-317. PubMed ID: 32860755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre.
    Herrmann K; Giovanella L; Santos A; Gear J; Kiratli PO; Kurth J; Denis-Bacelar AM; Hustinx R; Patt M; Wahl RL; Paez D; Giammarile F; Jadvar H; Pandit-Taskar N; Ghesani M; Kunikowska J
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2300-2309. PubMed ID: 35403861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Single photon emitting radiopharmaceuticals in oncology].
    Barna S; Garai I; Nagy G
    Magy Onkol; 2020 Jun; 64(2):98-103. PubMed ID: 32520002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nuclear medicine and radiopharmaceuticals].
    Sopena Novales P; Plancha Mansanet MC; Martinez Carsi C; Sopena Monforte R
    Radiologia; 2014 Jun; 56 Suppl 1():29-37. PubMed ID: 25304301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Life in Nuclear Medicine in Israel: A Conversation Between Ora Israel and Johannes Czernin.
    Israel O; Czernin J
    J Nucl Med; 2022 Sep; 63(9):1285-1287. PubMed ID: 36215517
    [No Abstract]   [Full Text] [Related]  

  • 36. Current experts' views on precision nuclear medicine imaging of phaeochromocytoma and paraganglioma.
    Taïeb D; Pacak K
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2223-2224. PubMed ID: 31332495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nuclear medicine and molecular imaging in clinical practice: yesterday, today and tomorrow].
    Sergienko VB; Ansheles AA
    Ter Arkh; 2021 Apr; 93(4):357-362. PubMed ID: 36286766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear medicine in Malaysia - Strengths and challenges for physicians after more than half a century of experience.
    Suppiah S
    Med J Malaysia; 2021 Jul; 76(4):451-453. PubMed ID: 34305103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiolabelled probes targeting infection and inflammation for personalized medicine.
    Signore A; Lauri C; Galli F
    Curr Pharm Des; 2014; 20(14):2338-45. PubMed ID: 24025100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiolabeled Compounds for Diagnosis and Treatment of Cancer.
    Kumar K
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.